Elixinol Wellness Limited

A$0.01As of Sun 8 Nov 2026, 12:00 UTC
ASX:EXLHealthcare
Country Australia
PE (Fwd) •••
TSR 9Y CAGR (57.06%)
Div yield —
ROE (53.00%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 2.30
PE TTM —
TSR TTM (50.00%)
Mkt cap A$2.484M
ROIC (27.65%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0059
(1.23%)
234.93%
Hold 8|11|9|10|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
29.90%
27.18%
19.96%
24.68%
Revenue$M
0.205
0.215
0.216
0.225
9.55%
13.09%
10.76%
9.08%
Peers (US$1.706M)
Cap (US$)
PE
2.550M
—
1.616M
—
1.644M
—
Capital
TTM
5Y
10Y
Leveragex
1.910
0.189
0.178
EBIT/Intx
0.215
1.099
0.920
Own earn%
48.51
(8.27)
(11.69)
Sh yield%
14.55
26.74
22.44
Owners
Insiders/Inst%
9.22
68.13
Short interest%
1.97
SBC / revenue%
4.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–3
$1 testx
0.0
Incr. ROIC%
2